Helicobacter pylori CagA(+) infection in gastric cancer patients;Zakażenie Helicobacter pylori CagA(+) u chorych na raka żoła̧dka

Polski Merkuriusz Lekarski

Volumn 13, Issue 75, 2002, Pages 216-220

  Ławniczak, Małgorzata ^a   Starzyńska, Teresa ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Gastric cancer; Helicobacter pylori CagA(+)

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER PATIENT; CANCER RISK; CARDIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; STOMACH CANCER; CASE CONTROL STUDY; HELICOBACTER INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; POLAND; RISK; RISK FACTOR; STOMACH TUMOR;

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CAGA PROTEIN, HELICOBACTER PYLORI;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLAND; RISK FACTORS; STOMACH NEOPLASMS;

EID: 2242448745     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ahlgren JD., Macdonald J.S.: Gastrointestinal oncology. J.B. Limmincott Company. Philadelphia. 1992.
2. Asaka M. i wsp.: Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer, 1994, 73, 11, 2691-2694.
3. Atherton J.C. i wsp.: Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori. J. Biol. Chem., 1995, 270, 30, 17771-17777.
4. Blanchard T., Czynin S.: Immunological determinants that may affect the Helicobacter pylori cancer risk (reviev article). Aliment. Pharmacol. Ther., 1998, 12, suppl. 1, 83-90.
5. Blaser M.J. i wsp.: Infection with Helicobacter pylori strains possesing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res., 1995, 55, 10, 2111-2115.
6. Bodner S.M.: Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 1992, 7, 743-749.
7. Cardin R. i wsp.: Helicobacter pylori CagA+ve infection increases the oxidative DNA damage of gastric mucosa. DDW, 2000, 1025.
8. Chang K.H. i wsp.: p53 overexpression in gastric adenocarcinoma with Helicobacter pylori infection. Yonsei Med. 1997, 38, 2, 117-124.
9. Chow Wong-Ho i wsp.: An inverse relation between cagA(+) strains of H. pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res., 1998, 58, 588-590.
10. Deguchi R. i wsp.: BAX and p53 gene mutations are frequent in gastric cancer patients with Cag-positive Helicobacter pylori infection. DDW. 2000, 4082.
11. Emad M. El-Omar: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 2000, 404, 23, 398-402.
12. Eslic D. i wsp.: Association of Helicobacter pylori infection with gastric carcinoma, a meta-analysis. Am. J. Gastroenter., 1999, 94, 9, 2373-2379.
13. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet, 1993, 341, 1359-1362.
14. Everhart J.E. i wsp.: Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J. Infect. Dis., 2000, 181, 4, 1359-1363.
15. Fallone C.A. i wsp.: Association of H. pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am J. Gastroenterol., 2000, 95, 3, 659-669.
16. Huang J.Q. i wsp.: Metaanalysis of relationship between Helicobacter pylori serpositivity and gastric cancer. Gastroenterology, 1998, 114, 1169-1179.
17. International Agency for Research on Cancer (1994), Schistiosomes, liver flukes and Helicobacter pylori (IARC monographs on the evaluation of carcinogenic risks to humans vol. 61). IARC Publications. Lyon. 1994.
18. Kikuchi S. i wsp.: Association between infections with CagA-positive ornegative strains of Helicobacter pylori and risk for gastric cancer in young adults. Am. J. Gastroenterol., 1999, 94, 3455-3459.
19. Konturek P.C. i wsp.: Helicobacter pylori-gastrin link in MALT lymphoma. Aliment. Pharmacol. Ther., 2000, 14, 1311-1318.
20. Kuipers E.J. i wsp.: Quasispecies developmentof Helicobacter pylori observedin paired isolates obtained years apart from the same host. J. Infectious Diseases, 2000, 181, 273-282.
21. Lauren P.: The two histological main types of gastric carcinoma, diffuse and so-colled intestinal-type carcinoma. Acta Pathol. Microbiol. Scand., 1965, 64, 31.
22. Miehlke S. i wsp.: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer, 2000, 87, 322-327
23. Odenbreit S. i wsp.: Translocation of Helicobacter pylori CagA into gastricepithelial cells by type IV secretion. Science, 2000, 287, 1497-1500.
24. Parsonnet J. i wsp.: Risk for gastric cancer with people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997, 40, 297-301.
25. Peek R.M. Jr. i wsp.: Role of Helicobacter pylori cagA (+) strains and specyfic host immune responses od development of premalignant and malignant lesions in the gastric cardia. Int. J. Cancer, 1999, 82, 4, 520-524.
26. Perez-Perez G.I. i wsp.: Country-specyfic constancy by age in cagA+ proportion of Helicobacter pylori infections. Int. J. Cancer, 1997, 72, 3, 453-456.
27. Rokkas T. i wsp.: Relationship of Helicobacter pylori CagA status to gastric cell proliferatin and apoptosis. Dig. Dis. Sci., 1999, 44, 3, 487-493.
28. Rugge M. i wsp.: Patients younger than 40 years with gastric carcinoma, Helicobacter pylori genotype and associated gastritis phenotype. Cancer. 1999, 85, 12, 2506-2511.
29. Segal E.D. i wsp.: Altered states, involvment of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad Sci USA, 1999, 96, 14559-14564.
30. Shimoyama T. i wsp.: CagA seropositivity associated with development of gastric cancer in Japanese population. J.Clin. Pathol., 1998, 51, 3, 225-228.
31. TNM Classification of malignant tumors. UICC-International Union against Cancer. Geneva. 1978.
32. Vicari J.J. i wsp.: The seroprevelence of cagA-positive Helicobacter pylori in the spectrum of gastroesophageal reflux disease. Gastroenterology, 1998, 115, 50-57.
33. Vorobjova T. i wsp.: Cag A protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia. Eur. J. Gastroenterol. Hepatol., 1998, 10, 1, 41-46.
34. Yamaoka Y. i wsp.: Relationship between Helicobacter pylori iceA, cagA, vacA status and clinical outcome, studies for four different countries. J. Clin. Microbiol., 1997, 37, 7, 2274-2278.
35. Yoshimura T. i wsp.: Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J. Clin. Pathol., 2000, 53, 7, 532-536.